• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED

1.19% ! 42.5¢
Market Cap $237.7M  !

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB 19/04/25 119 37K
19/04/25 Last post  vintage Comments Created with Sketch.  119  Views Created with Sketch.  37K 
DXB 16/04/25 8 3.3K
16/04/25 Last post  BT6487 Comments Created with Sketch.  8  Views Created with Sketch.  3.3K 
DXB 16/04/25 0 344
TRENDING NEWS

Download your free Thematic Insights report HERE

NEWS
22 Apr 2025
16/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  344 
DXB
DXB Chart
34 35 36
14/04/25 2.1K 891K
14/04/25 Last post  kates9999 Comments Created with Sketch.  2.1K  Views Created with Sketch.  891K 
DXB 10/04/25 0 373
10/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  373 
DXB
DXB Media thread.
5 6 7
09/04/25 398 204K
09/04/25 Last post  RYNZN Comments Created with Sketch.  398  Views Created with Sketch.  204K 
DXB 08/04/25 0 446
08/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  446 
DXB 04/04/25 0 414
04/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  414 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - DXB
16 Apr 14:54
 
Dimerix to Present at ASX CEO Connect
15 Apr 08:24
 
Application for quotation of securities - DXB
10 Apr 13:58
 
Securities Trading Policy Update
08 Apr 08:25
 
Application for quotation of securities - DXB
04 Apr 11:47
 
Application for quotation of securities - DXB
02 Apr 14:13
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
42.5¢
Change
0.005(1.19%)
Mkt cap ! $237.7M
Open High Low Value Volume
42.0¢ 42.8¢ 41.0¢ $438.2K 1.050M

Buyers (Bids)

No. Vol. Price($)
2 27500 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 13852 1
View Market Depth
Last trade - 16.10pm 21/04/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.